• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT 7.09% 68.0¢

OPTHEA LIMITED

Opthea Limited is an Australia-based biotechnology company. The Company is engaged in the... Opthea Limited is an Australia-based biotechnology company. The Company is engaged in the development and commercialization of therapies primarily for eye disease. The Company’s lead asset, OPT-302, is a novel biologic inhibitor of VEGF-C and VEGF-D, for use in combination with VEGF-A inhibitors for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The Company’s principal activities include the progression of the Company’s Phase III registration trials of OPT-302 for wet AMD. It also manufactures OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. The Company’s development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OPT
Opthea shares target raised on trial progress
14:14 30 6.5K
14:14 Last post  lordolean Comments Created with Sketch.  30  Views Created with Sketch.  6.5K 
OPT 01/05/24 0 338
01/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  338 
OPT 30/04/24 5 1.7K
Metals & Mining SECTOR NEWS

Alara Resources is driving Oman into a renewable renaissance with accelerating copper production

AUQ
10 May 2024
ALARA RESOURCES LIMITED
30/04/24 Last post  PigRace Comments Created with Sketch.  5  Views Created with Sketch.  1.7K 
OPT
Hang in there!!
2 3
29/04/24 155 68K
29/04/24 Last post  whytee Comments Created with Sketch.  155  Views Created with Sketch.  68K 
OPT 26/04/24 0 340
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  340 
OPT
Opthea Chart
4 5 6
16/04/24 309 169K
16/04/24 Last post  willxue123 Comments Created with Sketch.  309  Views Created with Sketch.  169K 
OPT 15/04/24 34 7.9K
15/04/24 Last post  whytee Comments Created with Sketch.  34  Views Created with Sketch.  7.9K 
OPT 15/04/24 0 239
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  239 

See All Discussions arrow Created with Sketch.

Timeline

Opthea Announces Presentations at Retina World Congress
01 May 09:44
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 08:29
 
Opthea Presents at the OIS Retina Innovation Summit at ARVO
26 Apr 08:17
 
Notification regarding unquoted securities - OPT
15 Apr 11:19
 
Notification regarding unquoted securities - OPT
15 Apr 10:54
 
Opthea Appoints John Han, PharmD, as VP Medical Affairs
09 Apr 08:23
 
View More arrow Created with Sketch.
(20min delay)
Last
68.0¢
Change
0.045(7.09%)
Mkt cap ! $450.7M
Open High Low Value Volume
67.0¢ 72.0¢ 65.0¢ $851.6K 1.250M

Buyers (Bids)

No. Vol. Price($)
2 14609 66.5¢
 

Sellers (Offers)

Price($) Vol. No.
68.0¢ 4154 1
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
67.5¢
  Change
0.045 ( 6.69 %)
Open High Low Volume
64.5¢ 71.5¢ 64.5¢ 95857
Last updated 15.56pm 10/05/2024 ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.